Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

View:
Post by DIYGuy on Jan 22, 2018 9:56am

I’m out

Sorry folks, I’m out. Took over a week to exit.

Why?
This Wednesday will mark HNSCC trial will be at 15 weeks with no news. No one can tell if if the cohort was full. 
Raised 2.1MM in October and had 1.2MM left at end of October.
Today 1.3MM shares from that raise become unrestricted.
If the gynaecology trial went well and they were happy with the 1.0mg/kg MTD then why didn’t they do a phase 2 trial right away instead of starting the HNSCC phase 1.
No increase in volume during the Healthcare conference.

If I were to buy back in at some point I would need to see the following:
HNSCC dose of 1.7mg/kg
Announcement of combination trial with radiotherapy for HNSCC
A raise of enough money to pay for the clinical phase 2 trial
Would like to see the U.S. office close

Good luck to all! I lost my shirt but couldn’t afford to lose my pants too.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities